Evidence map›Paper›PMID 23615909›Full record

ArticleThe Journal of biological chemistry2013

A LewisX glycoprotein screen identifies the low density lipoprotein receptor-related protein 1 (LRP1) as a modulator of oligodendrogenesis in mice.

Eva Hennen, Dina Safina, Ute Haussmann, Philipp Wörsdörfer, Frank Edenhofer, Ansgar Poetsch, Andreas Faissner

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Neural glycomics: the sweet side of nervous system functions.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Eva HennenDepartments of Cell Morphology and Molecular Neurobiology, D-44780 Bochum, Germany.
Dina SafinaDepartments of Cell Morphology and Molecular Neurobiology, D-44780 Bochum, Germany.
Ute HaussmannPlant Biochemistry, Ruhr-University Bochum, D-44780 Bochum, Germany.
Philipp WörsdörferStem Cell Engineering Group, Institute of Reconstructive Neurobiology, University of Bonn-Life and Brain Center, D-53105 Bonn, Germany.
Frank EdenhoferStem Cell Engineering Group, Institute of Reconstructive Neurobiology, University of Bonn-Life and Brain Center, D-53105 Bonn, Germany.
Ansgar PoetschPlant Biochemistry, Ruhr-University Bochum, D-44780 Bochum, Germany.
Andreas FaissnerDepartments of Cell Morphology and Molecular Neurobiology, D-44780 Bochum, Germany. Electronic address: andreas.faissner@rub.de.
University Hospitals of the Ruhr-University of Bochum · DERuhr University Bochum · DELife & Brain (Germany) · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the developing and adult CNS multipotent neural stem cells reside in distinct niches. Specific carbohydrates and glycoproteins are expressed in these niche microenvironments which are important regulators of stem cell maintenance and differentiation fate. LewisX (LeX), also known as stage-specific embryonic antigen-1 or CD15, is a defined carbohydrate moiety expressed in niche microenvironments of the developing and adult CNS. LeX-glycans are involved in stem cell proliferation, migration, and stemness. A few LeX carrier proteins are known, but a systematic analysis of the targets of LeX glycosylation in vivo has not been performed so far. Using LeX glycosylation as a biomarker we aimed to discover new glycoproteins with a potential functional relevance for CNS development. By immunoaffinity chromatography we enriched LeX glycoproteins from embryonic and postnatal mouse brains and used one-dimensional nLC-ESI-MS/MS for their identification. We could validate phosphacan, tenascin-C, and L1-CAM as major LeX carrier proteins present in vivo. Furthermore, we identified LRP1, a member of the LDL receptor family, as a new LeX carrier protein expressed by mouse neural stem cells. Surprisingly, little is known about LRP1 function for neural stem cells. Thus, we generated Lrp1 knock-out neural stem cells by Cre-mediated recombination and investigated their properties. Here, we provide first evidence that LRP1 is necessary for the differentiation of neural stem cells toward oligodendrocytes. However, this function is independent of LeX glycosylation.

Indexed as

AnimalsBrainCell DifferentiationCell ProliferationGlycosylationLewis X AntigenLow Density Lipoprotein Receptor-Related Protein-1MiceMice, KnockoutNerve Tissue ProteinsNeural Cell Adhesion Molecule L1Neural Stem CellsOligodendrogliaReceptor-Like Protein Tyrosine Phosphatases, Class 5Receptors, LDLTenascinLewis X AntigenLow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseNerve Tissue ProteinsNeural Cell Adhesion Molecule L1Receptor-Like Protein Tyrosine Phosphatases, Class 5Receptors, LDLTenascinTumor Suppressor ProteinsCarbohydrateDevelopmentDifferentiationExtracellular Matrix ProteinsGlycoproteinLipoprotein-like Receptor (LRP)Neural Stem Cell

Identifiers

PMID23615909
PMCPMC3675589
OpenAlexW2050293409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.